← Back to Search

Antioxidant

Betalain-rich Concentrate for Supplements (BET_RSE Trial)

N/A
Recruiting
Research Sponsored by Drexel University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy, recreationally active males and females age 18-40 will be recruited for this study
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-repeated sprint exercise, immediately post-repeated sprint exercise, and 5 min post-repeated sprint exercise
Awards & highlights

BET_RSE Trial Summary

"This trial will investigate the effects of a betalain-rich concentrate on exercise performance and recovery. Previous research suggests that betalains have antioxidant and anti-inflammatory properties that could enhance performance. However, this

Who is the study for?
This trial is for individuals interested in the potential performance and recovery benefits of a supplement. Specific eligibility criteria are not provided, so it's unclear who exactly can participate.Check my eligibility
What is being tested?
The study is testing whether a single dose of a betalain-rich concentrate (BRC), known for its antioxidant and anti-inflammatory effects, can improve repeated-sprint cycling performance and recovery compared to a placebo.See study design
What are the potential side effects?
Potential side effects are not listed, but as BRCs have antioxidant and anti-inflammatory properties, they may be minimal or related to digestive health.

BET_RSE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a healthy, active person between 18 and 40 years old.

BET_RSE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~each data point will be assessed immediately after each wingate sprint
This trial's timeline: 3 weeks for screening, Varies for treatment, and each data point will be assessed immediately after each wingate sprint for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Repeated Sprint Performance
Secondary outcome measures
Neuromuscular Fatigue

BET_RSE Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Betalain-rich ConcentrateExperimental Treatment1 Intervention
A single dose of a BRC supplementation
Group II: PlaceboPlacebo Group1 Intervention
A single dose of a placebo

Find a Location

Who is running the clinical trial?

Drexel UniversityLead Sponsor
150 Previous Clinical Trials
47,691 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible for me to participate in this clinical trial?

"To be eligible for enrollment in this research study, participants must fall between the ages of 18 and 40 years old and have no contraindications to supplements. The trial aims to recruit approximately 10 suitable candidates."

Answered by AI

Is the enrollment for this trial currently open?

"According to details on clinicaltrials.gov, this medical study is actively pursuing potential participants. The trial was first listed on 2/1/2024 and last modified on 2/15/2024."

Answered by AI

What is the overall count of participants who are registering for this research?

"Affirmative, the details on clinicaltrials.gov reveal that this investigation is actively seeking individuals. The trial was first listed on February 1st, 2024 and last revised on February 15th, 2024. This study aims to enroll 10 participants from a single site."

Answered by AI

Are individuals above the age of 35 being sought for enrollment in this research study?

"Recruitment for this study is targeting individuals over 18 years old but below the age of 40."

Answered by AI

Who else is applying?

What site did they apply to?
Drexel University - Health Sciences Building
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I am interested to find out more about the benefits of this supplement.
PatientReceived no prior treatments
~2 spots leftby Jun 2024